Načítá se...
Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer
BACKGROUND: c-Met and EGFR receptors are widely expressed on cancer cells; they are implicated in the development and progression of cancer through a plethora of effects on cell cycle progression, apoptosis, motility and metastasis and are potential targets for combination therapy. EGFR receptor tyr...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2669728/ https://ncbi.nlm.nih.gov/pubmed/19240370 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1477-3163.44372 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|